These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 11841142)

  • 1. Alprazolam-induced panic disorder.
    Bashir A; Swartz C
    J Am Board Fam Pract; 2002; 15(1):69-72. PubMed ID: 11841142
    [No Abstract]   [Full Text] [Related]  

  • 2. Personality dimensions in panic disorder before and after effective treatment.
    Starcevic V; Uhlenhuth EH
    Anxiety; 1996; 2(2):95-8. PubMed ID: 9160608
    [No Abstract]   [Full Text] [Related]  

  • 3. Efficacy studies of alprazolam in panic disorder.
    Spiegel DA
    Psychopharmacol Bull; 1998; 34(2):191-5. PubMed ID: 9640999
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Two cases of alprazolam-induced hyperprolactinemia in patients with panic disorder.
    Shioiri T; Kita N; Takahashi S
    Int Clin Psychopharmacol; 1996 Jun; 11(2):149-52. PubMed ID: 8803653
    [No Abstract]   [Full Text] [Related]  

  • 5. Decreased plasma cortisol level during alprazolam treatment of panic disorder: a case report.
    Fukuda M; Takazawa S; Nakagome K; Iwanami A; Hata A; Kasai K; Hiramatsu K
    Prog Neuropsychopharmacol Biol Psychiatry; 1998 Jul; 22(5):909-15. PubMed ID: 9723127
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The efficacy of alprazolam in the therapy of panic disorders].
    Diukova GM; Vorob'eva OV; Petrova EP; Smirnov SV; Tumalaeva ZN
    Zh Nevrol Psikhiatr Im S S Korsakova; 1995; 95(4):9-13. PubMed ID: 8533521
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma levels of tumor necrosis factor-alpha in patients with panic disorder: effect of alprazolam therapy.
    Brambilla F; Bellodi L; Perna G
    Psychiatry Res; 1999 Dec; 89(1):21-7. PubMed ID: 10643874
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The efficacy and safety of alprazolam versus other benzodiazepines in the treatment of panic disorder.
    Moylan S; Staples J; Ward SA; Rogerson J; Stein DJ; Berk M
    J Clin Psychopharmacol; 2011 Oct; 31(5):647-52. PubMed ID: 21869686
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Behavioural aggression in panic disorder after 8 weeks' treatment with alprazolam.
    Bond AJ; Curran HV; Bruce MS; O'Sullivan G; Shine P
    J Affect Disord; 1995 Dec; 35(3):117-23. PubMed ID: 8749839
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Xanax XR for panic disorder.
    Med Lett Drugs Ther; 2003 May; 45(1157):43-4. PubMed ID: 12766702
    [No Abstract]   [Full Text] [Related]  

  • 11. Cognitive style, alprazolam plasma levels, and treatment response in panic disorder.
    Uhlenhuth EH; Starcevic V; Qualls C; Antal EJ; Matuzas W; Javaid JI; Barnhill J
    Depress Anxiety; 2008; 25(8):E18-26. PubMed ID: 17960759
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Duloxetine-related panic attacks.
    Sabljić V; Rakun R; Ružić K; Grahovac T
    Psychiatr Danub; 2011 Mar; 23(1):114-6. PubMed ID: 21448113
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Subjective experience and attitudes towards participation in clinical trials among patients with anxiety disorders.
    Klein E; Malel D; Zilberman I; Lenox RH
    Isr J Psychiatry Relat Sci; 1997; 34(4):265-9. PubMed ID: 9409083
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A naturalistic 6-year follow-up study of patients with panic disorder.
    Lepola U; Koponen H; Leinonen E
    Acta Psychiatr Scand; 1996 Mar; 93(3):181-3. PubMed ID: 8739663
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Absence of neuropsychologic deficits in patients receiving long-term treatment with alprazolam-XR for panic disorder.
    Gladsjo JA; Rapaport MH; McKinney R; Auerbach M; Hahn T; Rabin A; Oliver T; Haze A; Judd LL
    J Clin Psychopharmacol; 2001 Apr; 21(2):131-8. PubMed ID: 11270908
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical picture and treatment of agoraphobia with panic disorder].
    Litvintsev SV; Reznik AM; Kvashnina NV; Arbuzov AL; Krylov KE
    Voen Med Zh; 2003 Jun; 324(6):53-9. PubMed ID: 12916423
    [No Abstract]   [Full Text] [Related]  

  • 17. Commentary on 'The role of alprazolam for the treatment of panic disorder in Australia'.
    Lampe L
    Aust N Z J Psychiatry; 2012 Mar; 46(3):273-4. PubMed ID: 22391286
    [No Abstract]   [Full Text] [Related]  

  • 18. Is there anything new on the use of psychotropic drugs during pregnancy?
    Shader RI
    J Clin Psychopharmacol; 1994 Dec; 14(6):438. PubMed ID: 7884034
    [No Abstract]   [Full Text] [Related]  

  • 19. Panic symptoms without report of anxiety.
    Schreier H; Martinez K
    J Am Acad Child Adolesc Psychiatry; 2005 May; 44(5):407-8. PubMed ID: 15843761
    [No Abstract]   [Full Text] [Related]  

  • 20. Abrupt discontinuation of alprazolam and cognitive style in patients with panic disorder: early effects on mood, performance, and vital signs.
    Uhlenhuth EH; Starcevic V; Qualls C; Antal EJ; Matuzas W; Javaid JI; Barnhill J
    J Clin Psychopharmacol; 2006 Oct; 26(5):519-23. PubMed ID: 16974197
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.